Chemotherapy options in ovarian carcinoma — a dose intensity perspective
- 1 January 1995
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Importance of Multiagent Chemotherapy Regimens in Ovarian Carcinoma: Dose Intensity AnalysisJNCI Journal of the National Cancer Institute, 1993
- Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerThe Lancet, 1992
- Meta-analysis of surgery in advanced ovarian carcinoma: Ismaximum cytoreductive surgery an independent determinant of prognosis?American Journal of Obstetrics and Gynecology, 1992
- Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1991
- A Randomized Study of High-Dose versus Low-Dose cis-Platinum Combined with Cyclophosphamide in the Treatment of Advanced Ovarian CancerChemotherapy, 1989
- Therapy of ovarian carcinoma: The relationship of dose level and treatment intensity to survivalGynecologic Oncology, 1988
- Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.Journal of Clinical Oncology, 1987
- A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma.Journal of Clinical Oncology, 1986
- High-Dose Cisplatin in Hypertonic SalineAnnals of Internal Medicine, 1984
- Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinCancer, 1981